WO2005094682A1 - Method and apparatus for electrical stimulation to enhance lancing device performance - Google Patents

Method and apparatus for electrical stimulation to enhance lancing device performance Download PDF

Info

Publication number
WO2005094682A1
WO2005094682A1 PCT/EP2005/002155 EP2005002155W WO2005094682A1 WO 2005094682 A1 WO2005094682 A1 WO 2005094682A1 EP 2005002155 W EP2005002155 W EP 2005002155W WO 2005094682 A1 WO2005094682 A1 WO 2005094682A1
Authority
WO
WIPO (PCT)
Prior art keywords
site
skin
electrical energy
bodily fluid
engorgement
Prior art date
Application number
PCT/EP2005/002155
Other languages
French (fr)
Inventor
Frank A. Chan
Original Assignee
Roche Diagnostics Gmbh
F.Hoffmann-La Roche Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh, F.Hoffmann-La Roche Ag filed Critical Roche Diagnostics Gmbh
Priority to EP05715640A priority Critical patent/EP1722683A1/en
Priority to JP2007501200A priority patent/JP2007526057A/en
Priority to CA002557804A priority patent/CA2557804A1/en
Publication of WO2005094682A1 publication Critical patent/WO2005094682A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150015Source of blood
    • A61B5/150022Source of blood for capillary blood or interstitial fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150061Means for enhancing collection
    • A61B5/150091Means for enhancing collection by electricity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150053Details for enhanced collection of blood or interstitial fluid at the sample site, e.g. by applying compression, heat, vibration, ultrasound, suction or vacuum to tissue; for reduction of pain or discomfort; Skin piercing elements, e.g. blades, needles, lancets or canulas, with adjustable piercing speed
    • A61B5/150106Means for reducing pain or discomfort applied before puncturing; desensitising the skin at the location where body is to be pierced
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150412Pointed piercing elements, e.g. needles, lancets for piercing the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/150007Details
    • A61B5/150374Details of piercing elements or protective means for preventing accidental injuries by such piercing elements
    • A61B5/150381Design of piercing elements
    • A61B5/150503Single-ended needles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15103Piercing procedure
    • A61B5/15107Piercing being assisted by a triggering mechanism
    • A61B5/15113Manually triggered, i.e. the triggering requires a deliberate action by the user such as pressing a drive button
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15117Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising biased elements, resilient elements or a spring, e.g. a helical spring, leaf spring, or elastic strap
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15121Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising piezos
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15123Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising magnets or solenoids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15101Details
    • A61B5/15115Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids
    • A61B5/15125Driving means for propelling the piercing element to pierce the skin, e.g. comprising mechanisms based on shape memory alloys, magnetism, solenoids, piezoelectric effect, biased elements, resilient elements, vacuum or compressed fluids comprising a vacuum or compressed fluids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/15Devices for taking samples of blood
    • A61B5/151Devices specially adapted for taking samples of capillary blood, e.g. by lancets, needles or blades
    • A61B5/15186Devices loaded with a single lancet, i.e. a single lancet with or without a casing is loaded into a reusable drive device and then discarded after use; drive devices reloadable for multiple use
    • A61B5/15188Constructional features of reusable driving devices
    • A61B5/1519Constructional features of reusable driving devices comprising driving means, e.g. a spring, for propelling the piercing unit
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/3756Casings with electrodes thereon, e.g. leadless stimulators

Definitions

  • the present invention relates to devices and methods for obtaining samples of blood and other fluids from the body for analysis or processing.
  • a second area of effort focuses on stimulating increased presence of blood so that at least a minimum blood sample size is collected after lancing for accurate testing.
  • the invention in one form, relates to a device for obtaining a sample of bodily fluid through the skin.
  • the device comprises a housing and electrodes on the housing positioned to contact a site on the skin.
  • An electrical signal generator applies electrical energy to the electrodes in sufficient quantity to stimulate the skin at the site to accomplish at least one of pain masking and bodily fluid engorgement at the site.
  • a skin-lancing device mounted in the housing directs a skin-lancing medium against the skin at the site to form an incision therein subsequent to the application of electrical energy.
  • the invention in another form, relates to a method obtaining a sample of bodily fluid through the skin.
  • the method comprises applying electrical energy to a sampling site on the skin of sufficient quantity to stimulate the skin at the site to accomplish at least one of pain masking and bodily fluid engorgement at the site. Subsequently, an incision is formed at the site to remove a sample of bodily fluid.
  • Fig. 1 shows a highly schematic drawing showing the application of the present invention to a lancing device.
  • Fig. 2 shows a perspective view of one set of electrodes and skin contacting end wall configuration for use in the lancing device of Fig. 1.
  • Fig. 3 shows an alternative array of electrodes and end wall design for the lancing device of Fig. 1.
  • Fig. 4 shows a simplified circuit diagram for the signal generator shown schematically in Fig. 1. DESCRIPTION OF THE SELECTED EMBODIMENT
  • the present invention uses electrical treatment of a skin sampling site to achieve one or both of pain masking and blood engorgement before a lancing device causes an incision to be made for blood sampling.
  • a lancing de-vice 10 comprising a housing 12 which may be annular in form. Housing 12 has skin contacting end cap 14 which may take the form shown in Fig. 2 or Fig. 3 as discussed below. End cap 14 has an end section 16 removably connected to the end 18 of housing 12. Mounted within housing 12 is a lancet holder 20 com ected to a lancet actuator 22. Lancet actuator 22 is responsive to an operator controlled button 24 through interconnection 26 to cause lancet carrier 22 to displace a lancet 28 to the left as viewed in Fig. 1 to pierce the skin adjacent to device 10.
  • lancet actuator 22 is adapted to have a controlled rate of displacement and depth of penetration to provide optimum withdrawal of bodily fluid such as blood.
  • Lancet 28 is removable so that it may b e disposed in appropriate fashion after a test is completed.
  • Lancet actuator 22 may take one of many diffexent forms to achieve a controlled rate of displacement and penetration depth for the lancet 28. Lancet actuator 22 may be mechanical in form using a spring-like device. It may also be electrically or pneumatically actuated. As herein shown, a capillary passage 35 leads from the mouth of passage 34 adjacent the incision of lancet 28 to a sensor 37 which gives an indication of bodily fluid parameter or condition through optical read-out 39. Alternatively, lancet 28 may to pierce the skin so that a sufficient quantity of blood may accumulate on the skin for application to a test strip (not shown). It should be noted that to hose skilled in the art, the unit may be used to collect blood samples through the lancet 28 and provide still another way to integrate the testing process.
  • the lancing device cap 14 has a plurality of electrodes 30 and 32 grouped within sets.
  • the electrodes 30 and 32 are positioned in an array around the periphery of an opening 34 for lancet 28.
  • the cap 14 may take the form shown in Fig. 2 or in Fig. 3.
  • the electrode sets 30 and 32 may be deployed on the head in a variety of arrays to achieve the objectives of the present invention. They may be positioned in a random fashion with pairs positioned adjacent one another without any specific orientation. Alternatively, the pairs may be arranged in circumferential fashion around the opening 34. A further orientation may be in radial arcays. Based on present experimentation, the random orientation of the electrodes allowed achievement of the objectives of the invention. It should be apparent to those skilled in the art that the electrodes may be oriented other than in the random fashion and still achieve objectives of the present invention.
  • the electrodes 30 and 32 are connected by lines 36 and 38 to a signal generator and controller 40.
  • Signal generator 40 is supplied with electrical power from a power source such as a battery 42 via lines 44 and 46.
  • signal generator 40 comprises an integrated circuit (IC) oscillator 70 having input leads 72 and 74.
  • Oscillator 70 provides an output on terminal 3 via resistor 76 to the gate of a transistor 78.
  • Transistor 78 is connected between line 44 and 46 on the input to a step up transformer 80.
  • Output terminal 7 of oscillator 70 provides an input to a variable resistor 82 so as to control the frequency of oscillator 70.
  • the output side of transformer 80 is connected to output leads 36 and 38 which lead to the electrodes 30 and 32.
  • Capacitors 84 and 86 provide smoothing of the output wave.
  • the transistor 78 acts to pass current through the input side of transformer 80 in approximately a square wave.
  • the transformer 80 increases the voltage output to an equivalent square wave on the output side.
  • Capacitor 86 smoothes the wave form so that it ends up being a high voltage AC waveform.
  • Variable resistor 82 is adjustable by means of an operator-manipulated knob 48 via an appropriate connection indicated by dashed line 50.
  • Signal generator 40 is of a type that generates a tiigh voltage AC wave.
  • the voltage level can be approximately from 10 to 25 kilovolts.
  • Tlxe frequency preferably is 20 Hz.
  • the signal generator controller 44 can be adapted to control the signal generator 40 through a range of frequencies, voltages and at low current (i.e. 100 miliamps) as appropriate for the applications described below.
  • the present invention relies on the principle of electrical treatment prior to the lancing of the skin to accomplish at least one of pain masking and bodily fluid or blood engorgement.
  • the electrical pulses stimulate the peripheral terminals of sensory neurons in the body, which cause the release of bioactive substances.
  • the e substances for the most part are neuropeptides; substance P and calcitonian gene related peptide. They in turn act on target cells in the periphery of the applied area such as masked cells, immune cells and smooth muscle producing inflammation. This is characterized " by redness and warmth, an indication of vasodialation. This phenomenon is known as neurogenetic inflammation.
  • the success rate can further be enhanced by using an expression cap shown in Fig. 2 to permit mechanical compression of the skin site subsequent to lancing.
  • the cap 14 has a plurality of electrode pairs 30 and 32 on a skin contacting face 52 in an array around central opening 34 through which the lancet 28 extends when it is actuated.
  • skin contacting face 52 is curved in a negative sigmoid shape with an .annular concave section 56 leading from opening 34 to an annular convex section 58.
  • the purpose of this configuration is to allow application of the skin contacting face 52 to the sldn site that has been lanced to force bodily fluids such as blood to the incision point in sufficient quantity to obtain a sample for blood analysis.
  • the electrical energy is applied for a longer duration prior to making the incision on the skin.
  • This electrical power can be used through the same electrode pairs shown in Figures 1 and 2 or it m-ay be as embodied in the device of figure 3 having a flat faced skin contacting cap 60 with a plurality of electrode pairs 62 and 64 positioned to generally surround a central opening 66 for the lancing device.
  • the head 60 is connected to a housing 68 containing the elements sho vn in schematic fashion in Fig. 1.
  • the electrode pairs 62 _, 64 may be oriented in random, circumferential, or radial fashion.
  • the electrodes deliver electrical stimulation to the area to be lanced.
  • This electrical stimulation depending upon its nature and character, stimulates the sensory neutrons which manipulate the transmission of signals of afferent information to the spinal cord.
  • Electrical stimulation can target the A-delta and C-fibers which deplete neuropeptides content in the terminal ends of the fibers or target the A-beta fiber causing an abundance of signals to be released.
  • the type of outcome is dependent upon the typ& and intensity of the electrical stimulus such as pulse rate and duration of applied stimulus. This prevents the neuron's ability to transfer information to the central nervous system with respect to trauma or pain to tissues.
  • the stimulus may also target A-beta fibers, which causes an abundance of neuropeptides being released.
  • A-beta fibers are associated with the detection of pressure. As the lancing occurs, the signals transmitted by the A-delta and C-fibers are clouded by the abundance of A-beta fiber signals. This phenomenon tends to reduce ttie sensitivity of neociceptive pain. To insure adaptability to as many users as possible because of different individual stimulation thresholds, the device is adjustable for the intensity and pulse rate.
  • Table 2 shows the pain rating with and without electrical stimulation. Xhe electrical stimulation was at 20 Hz for at least 60 seconds prior to lancing. A redaction and/or increase in tolerance of pain were achieved with electrical stimulation. It should be apparent to those skilled in the art that the parameters set forth in this description are for illustration purposes only based on current investigation and are not to be construed or interpreted as in any way limiting the range of electrical parameters applied within the scope of present invention.
  • the electrical stimulation is applied for approximately 60 seconds and above. After 30 seconds the engorgement of the site with blood is achieved and after approximately 60 seconds the pain masking is realized.
  • the lancing device is fired to lance the skin. Subsequent to lancing, the skin contacting surface 52 may be employed to express bodily fluid or blood from the incision for application to a test strip. Alternatively, different forms of lancing devices may be used which extract a sample for delivery to another test device.

Abstract

A lancing device (10) where electrical stimulation is applied to a skin sampling site prior to making an incision to achieve at least one of pain masking and bodily fluid engorgement at the site. The electrical stimulation is supplied by a low current high voltage AC signal generator (40) in sufficient quantities to produce vasodialation and/or pain masking.

Description

METHOD AND APPARATUS FOR ELECTRICAL STIMULATION TO ENHANCE LANCING DEVICE PERFORMANCE
FIELD OF THE INVENTION
The present invention relates to devices and methods for obtaining samples of blood and other fluids from the body for analysis or processing.
BACKGROUND OF THE INVENTION
The wide-spread application of devices for extracting samples of bodily fluids for analysis such as determining blood glucose level has led to significant activity in the field to address several problems and issues. These are the problems of pain when the skin is pierced by a lance and the problem of insuring a sufficient quantity of blood at the surface to obtain a proper sample size. Many proposals have been made to achieve these ends.
In terms of pain management there are there have been developments relative to the shape of the lance itself. These have involved depth of cuts so that the depth is the minimum necessary to extract a sample. In addition, the rate of incision has been controlled so that with a faster incision, pain is diminished.
Other activities have focused on pain masking by using vibrators and even patient distractions so that a patient is not focusing on the pain that will be experienced during the process.
A second area of effort focuses on stimulating increased presence of blood so that at least a minimum blood sample size is collected after lancing for accurate testing. Some research has focused on ways of palpating the skin to express additional blood, either manually or by various mechanisms. Other researchers have proposed using vibration, ultrasonics and other stimulation to increase blood flow. However, such devices are either too crude and simplistic or are overly complicated and expensive. The above activity is brought into increased focus when alternate site testing (AST) is adopted to sample bodily fluids from locations other than the fingers. Both pain minimization and blood engorgement need to be managed.
SUMMARY OF THE INVENTION
The invention, in one form, relates to a device for obtaining a sample of bodily fluid through the skin. The device comprises a housing and electrodes on the housing positioned to contact a site on the skin. An electrical signal generator applies electrical energy to the electrodes in sufficient quantity to stimulate the skin at the site to accomplish at least one of pain masking and bodily fluid engorgement at the site. A skin-lancing device mounted in the housing directs a skin-lancing medium against the skin at the site to form an incision therein subsequent to the application of electrical energy.
In another form, the invention relates to a method obtaining a sample of bodily fluid through the skin. The method comprises applying electrical energy to a sampling site on the skin of sufficient quantity to stimulate the skin at the site to accomplish at least one of pain masking and bodily fluid engorgement at the site. Subsequently, an incision is formed at the site to remove a sample of bodily fluid.
BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 shows a highly schematic drawing showing the application of the present invention to a lancing device.
Fig. 2 shows a perspective view of one set of electrodes and skin contacting end wall configuration for use in the lancing device of Fig. 1.
Fig. 3 shows an alternative array of electrodes and end wall design for the lancing device of Fig. 1.
Fig. 4 shows a simplified circuit diagram for the signal generator shown schematically in Fig. 1. DESCRIPTION OF THE SELECTED EMBODIMENT
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to the embodiments illustrated herein and specific language will be used to describe the same. It will nevertheless be understood that no limitation of the scope of the invention is thereby intended. Any alterations and further modifications in the described processes, systems or devices, and any further -applications of the principles of the invention as described herein, are contemplated as would normally occur to one skilled in the art to which the invention relates.
The present invention uses electrical treatment of a skin sampling site to achieve one or both of pain masking and blood engorgement before a lancing device causes an incision to be made for blood sampling.
Referring to Fig. 1, there is shown a lancing de-vice 10 comprising a housing 12 which may be annular in form. Housing 12 has skin contacting end cap 14 which may take the form shown in Fig. 2 or Fig. 3 as discussed below. End cap 14 has an end section 16 removably connected to the end 18 of housing 12. Mounted within housing 12 is a lancet holder 20 com ected to a lancet actuator 22. Lancet actuator 22 is responsive to an operator controlled button 24 through interconnection 26 to cause lancet carrier 22 to displace a lancet 28 to the left as viewed in Fig. 1 to pierce the skin adjacent to device 10. It is also possible to use the pressure of cap 14 against a skin site through an interconnection (not shown) with lancet actuator 22 to displace lancet 28. Lancet actuator 22 is adapted to have a controlled rate of displacement and depth of penetration to provide optimum withdrawal of bodily fluid such as blood. Lancet 28 is removable so that it may b e disposed in appropriate fashion after a test is completed. Although making a mechanical incision is described for piercing the skin, it should be apparent that other mechanisms for making an incision, such as a laser, could be used with the present invention.
Lancet actuator 22 may take one of many diffexent forms to achieve a controlled rate of displacement and penetration depth for the lancet 28. Lancet actuator 22 may be mechanical in form using a spring-like device. It may also be electrically or pneumatically actuated. As herein shown, a capillary passage 35 leads from the mouth of passage 34 adjacent the incision of lancet 28 to a sensor 37 which gives an indication of bodily fluid parameter or condition through optical read-out 39. Alternatively, lancet 28 may to pierce the skin so that a sufficient quantity of blood may accumulate on the skin for application to a test strip (not shown). It should be noted that to hose skilled in the art, the unit may be used to collect blood samples through the lancet 28 and provide still another way to integrate the testing process.
The advantages and features of the present invention will be seen to be equally applicable to the range of devices used to sample blood for glucose measurement and other applications. More specifically, the invention would be applicable to devices that sample and analyze the blood in a single unit.
In accordance with the present invention, the lancing device cap 14 has a plurality of electrodes 30 and 32 grouped within sets. The electrodes 30 and 32 are positioned in an array around the periphery of an opening 34 for lancet 28. As described below, the cap 14 may take the form shown in Fig. 2 or in Fig. 3. The electrode sets 30 and 32 may be deployed on the head in a variety of arrays to achieve the objectives of the present invention. They may be positioned in a random fashion with pairs positioned adjacent one another without any specific orientation. Alternatively, the pairs may be arranged in circumferential fashion around the opening 34. A further orientation may be in radial arcays. Based on present experimentation, the random orientation of the electrodes allowed achievement of the objectives of the invention. It should be apparent to those skilled in the art that the electrodes may be oriented other than in the random fashion and still achieve objectives of the present invention.
As shown in Fig. 1, the electrodes 30 and 32 are connected by lines 36 and 38 to a signal generator and controller 40. Signal generator 40 is supplied with electrical power from a power source such as a battery 42 via lines 44 and 46. As shown in Fig. 4, signal generator 40 comprises an integrated circuit (IC) oscillator 70 having input leads 72 and 74. Oscillator 70 provides an output on terminal 3 via resistor 76 to the gate of a transistor 78. Transistor 78 is connected between line 44 and 46 on the input to a step up transformer 80. Output terminal 7 of oscillator 70 provides an input to a variable resistor 82 so as to control the frequency of oscillator 70. The output side of transformer 80 is connected to output leads 36 and 38 which lead to the electrodes 30 and 32. Capacitors 84 and 86 provide smoothing of the output wave. The transistor 78 acts to pass current through the input side of transformer 80 in approximately a square wave. The transformer 80 increases the voltage output to an equivalent square wave on the output side. Capacitor 86 smoothes the wave form so that it ends up being a high voltage AC waveform. Variable resistor 82 is adjustable by means of an operator-manipulated knob 48 via an appropriate connection indicated by dashed line 50.
Signal generator 40, as illustrated, is of a type that generates a tiigh voltage AC wave. The voltage level can be approximately from 10 to 25 kilovolts. Tlxe frequency preferably is 20 Hz. The signal generator controller 44 can be adapted to control the signal generator 40 through a range of frequencies, voltages and at low current (i.e. 100 miliamps) as appropriate for the applications described below.
The present invention relies on the principle of electrical treatment prior to the lancing of the skin to accomplish at least one of pain masking and bodily fluid or blood engorgement.
In one aspect, the electrical pulses stimulate the peripheral terminals of sensory neurons in the body, which cause the release of bioactive substances. The e substances for the most part are neuropeptides; substance P and calcitonian gene related peptide. They in turn act on target cells in the periphery of the applied area such as masked cells, immune cells and smooth muscle producing inflammation. This is characterized "by redness and warmth, an indication of vasodialation. This phenomenon is known as neurogenetic inflammation.
It has been determined that application of electrical stimulus for a period of approximately 30 seconds will produce vasodialation. Accordingly, after the application of the electrical energy, the lancet 28 is actuated to pierce the skin and produce a quantity of blood which is enhanced by the pretreatment of the surface to produce vasodilatation. In tests outlined in table 1, there is as shown a 77% increase in average blood volume and a 16% increase in the success rate to obtain .75 microliters of a sample. For this test, the voltage level was 16 kilovolts at 20 Hz. It should be apparent to those skilled in the art that the electrical parameters set forth in this description are for illustration purposes only based on current investigations and are not to be construed or interpreted as in any way limiting the range of electrical parameters applied within the scope of the present nrvention. Table 1.
Figure imgf000008_0001
The success rate can further be enhanced by using an expression cap shown in Fig. 2 to permit mechanical compression of the skin site subsequent to lancing. The cap 14 has a plurality of electrode pairs 30 and 32 on a skin contacting face 52 in an array around central opening 34 through which the lancet 28 extends when it is actuated. As shown in Fig. 2, skin contacting face 52 is curved in a negative sigmoid shape with an .annular concave section 56 leading from opening 34 to an annular convex section 58. The purpose of this configuration is to allow application of the skin contacting face 52 to the sldn site that has been lanced to force bodily fluids such as blood to the incision point in sufficient quantity to obtain a sample for blood analysis.
In order for electrical stimulation to be used to mask pain, the electrical energy is applied for a longer duration prior to making the incision on the skin. This electrical power can be used through the same electrode pairs shown in Figures 1 and 2 or it m-ay be as embodied in the device of figure 3 having a flat faced skin contacting cap 60 with a plurality of electrode pairs 62 and 64 positioned to generally surround a central opening 66 for the lancing device. The head 60 is connected to a housing 68 containing the elements sho vn in schematic fashion in Fig. 1. As is the case with Figures 1 and 2, the electrode pairs 62 _, 64 may be oriented in random, circumferential, or radial fashion.
Using either array, the electrodes deliver electrical stimulation to the area to be lanced. This electrical stimulation, depending upon its nature and character, stimulates the sensory neutrons which manipulate the transmission of signals of afferent information to the spinal cord. Electrical stimulation can target the A-delta and C-fibers which deplete neuropeptides content in the terminal ends of the fibers or target the A-beta fiber causing an abundance of signals to be released. The type of outcome is dependent upon the typ& and intensity of the electrical stimulus such as pulse rate and duration of applied stimulus. This prevents the neuron's ability to transfer information to the central nervous system with respect to trauma or pain to tissues. The stimulus may also target A-beta fibers, which causes an abundance of neuropeptides being released. A-beta fibers are associated with the detection of pressure. As the lancing occurs, the signals transmitted by the A-delta and C-fibers are clouded by the abundance of A-beta fiber signals. This phenomenon tends to reduce ttie sensitivity of neociceptive pain. To insure adaptability to as many users as possible because of different individual stimulation thresholds, the device is adjustable for the intensity and pulse rate.
Table 2 shows the pain rating with and without electrical stimulation. Xhe electrical stimulation was at 20 Hz for at least 60 seconds prior to lancing. A redaction and/or increase in tolerance of pain were achieved with electrical stimulation. It should be apparent to those skilled in the art that the parameters set forth in this description are for illustration purposes only based on current investigation and are not to be construed or interpreted as in any way limiting the range of electrical parameters applied within the scope of present invention.
Table 2.
Figure imgf000009_0001
2* : Pain intensity of 2 but much more tolerable pain
When the device is intended to be used for both pain masldng and engorgement of bodily fluids, the electrical stimulation is applied for approximately 60 seconds and above. After 30 seconds the engorgement of the site with blood is achieved and after approximately 60 seconds the pain masking is realized. Once the pain masldng is achieved, the lancing device is fired to lance the skin. Subsequent to lancing, the skin contacting surface 52 may be employed to express bodily fluid or blood from the incision for application to a test strip. Alternatively, different forms of lancing devices may be used which extract a sample for delivery to another test device.
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same is to be considered as illustrative and not restrictive in character, it being understood that only the preferred embodiment has been shown and described and that all changes and modifications that come within the spirit of the invention are desired to b e protected.

Claims

WHAT IS CLAIMED
1. Apparatus for obtaining a sample of bodily fluid through the sldn, said apparatus comprising: a housing, a plurality of electrodes on said housing and positioned to contact a site on the skin, an electrical signal generator for applying electrical energy to said electrodes, said electrical signal generator supplying electrical energy in sufficient quantity to stimulate the skin at said site to accomplish at least one of pain masking and bodily fbuid engorgement at said site, and a skin-lancing device mounted in said housing for directing a skin-lancing medium against the skin at said site to form an incision therein subsequent to the application of said electrical energy.
2. Apparatus as claimed in claim 1 wherein said electrodes are positioned in an array to surround said site.
3. Apparatus as claimed in claim 2 wherein said skin-lancing medimm is directed through the middle of said electrode array into said skin.
4. Apparatus as claimed in claim 1 wherein said electrical signal generator supplies high voltage AC.
5. Apparatus as claimed in claim 4 wherein the quantity of electrical energy is less for engorgement than pain masldng.
6. Apparatus as claimed in claim 5 wherein said electrical energy is applied to said site for approximately 30 seconds, to produce bodily fluid engorgement.
7. Apparatus as claimed in claim 6 wherein said electrical power su-pply is adapted to apply electrical energy for at least one minute for pain masldng and engorgement.
8. Apparatus as claimed in claim 4 where in the voltage range of said electrical power supply is from between approximately 10 to 25 kilovolts at low current (i .e. 100 miliamps).
9. Apparatus as claimed in claim 2 wherein said unit has a plurality of electrode pairs in an array surrounding said site.
10. Apparatus as claimed in claim 1 wherein said apparatus is a self-contained unit.
11. Apparatus as claimed in claim 10 wherein said electrical signal generator has an adjustable level of electrical energy.
12. Apparatus as claimed in claim 1 wherein said electrical signal generator is adapted to adjust the level of electrical energy.
13. Apparatus as claimed in claim 1 further comprising a device adjacent said skin lancing device for indicating a bodily fluid parameter
14. Apparatus as claimed in claim 13 further comprising a capillary passage leading from the skin incision to said bodily fluid indicator device.
15. A method for obtaining a sample of bodily fluid through the skin, said method comprising: applying electrical energy to a sampling site on said skin of sufficient quantity to stimulate the sldn at said site to accomplish at least one of pain masldng and bodily fluid engorgement at said site, and subsequently maldng an incision at said site to remove a sample of bodily fluid.
16. A method as claimed in claim 15 wherein said electrical energy is applied in an arra-y around said site.
17. A method as claimed in claim 15 wherein said electrical energy is applied in the form of high voltage AC.
18. A method as claimed in claim 17 wherein a lower level of electrical energy is applied! for engorgement.
19. A method as claimed in claim 18 wherein said electrical energy is applied for approximately 30 seconds for bodily fluid engorgement.
20. A method as claimed in claim 18 wherein said electrical energy is applied for at least 60 seconds for pain masldng and engorgement
21. A method as claimed in claim 17 wherein the voltage range is between approximately 15 and 25 kilo volts.
22. A method as claimed in claim 17 wherein the electrical energy is adjustable.
23. A method as claimed in claim 15 comprising the further step of compressing the site subsequent to making an incision for further enhancing bodily fluid expression.
PCT/EP2005/002155 2004-03-02 2005-03-02 Method and apparatus for electrical stimulation to enhance lancing device performance WO2005094682A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP05715640A EP1722683A1 (en) 2004-03-02 2005-03-02 Method and apparatus for electrical stimulation to enhance lancing device performance
JP2007501200A JP2007526057A (en) 2004-03-02 2005-03-02 Method and apparatus for electrical stimulation to enhance the performance of an incision device
CA002557804A CA2557804A1 (en) 2004-03-02 2005-03-02 Method and apparatus for electrical stimulation to enhance lancing device performance

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/791,173 2004-03-02
US10/791,173 US20050209625A1 (en) 2004-03-02 2004-03-02 Method and apparatus for electrical stimulation to enhance lancing device performance

Publications (1)

Publication Number Publication Date
WO2005094682A1 true WO2005094682A1 (en) 2005-10-13

Family

ID=34962579

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2005/002155 WO2005094682A1 (en) 2004-03-02 2005-03-02 Method and apparatus for electrical stimulation to enhance lancing device performance

Country Status (6)

Country Link
US (1) US20050209625A1 (en)
EP (1) EP1722683A1 (en)
JP (1) JP2007526057A (en)
CN (1) CN1925789A (en)
CA (1) CA2557804A1 (en)
WO (1) WO2005094682A1 (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009016634A3 (en) * 2007-08-01 2009-03-26 Syneron Medical Ltd Method and device for collagen growth stimulation
US8321012B2 (en) 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
CN102921102A (en) * 2006-03-03 2013-02-13 基因特伦尼克斯公司 Method and device for treating microscopic tumors remaining in tissues following surgical resection
US10610684B2 (en) 2008-01-17 2020-04-07 Genetronics, Inc. Variable current density single needle electroporation system and method

Families Citing this family (57)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6036924A (en) 1997-12-04 2000-03-14 Hewlett-Packard Company Cassette of lancet cartridges for sampling blood
US6391005B1 (en) 1998-03-30 2002-05-21 Agilent Technologies, Inc. Apparatus and method for penetration with shaft having a sensor for sensing penetration depth
US8641644B2 (en) 2000-11-21 2014-02-04 Sanofi-Aventis Deutschland Gmbh Blood testing apparatus having a rotatable cartridge with multiple lancing elements and testing means
US7316700B2 (en) 2001-06-12 2008-01-08 Pelikan Technologies, Inc. Self optimizing lancing device with adaptation means to temporal variations in cutaneous properties
ATE497731T1 (en) 2001-06-12 2011-02-15 Pelikan Technologies Inc DEVICE FOR INCREASING THE SUCCESS RATE OF BLOOD YIELD OBTAINED BY A FINGER PICK
US9795747B2 (en) 2010-06-02 2017-10-24 Sanofi-Aventis Deutschland Gmbh Methods and apparatus for lancet actuation
US7344507B2 (en) 2002-04-19 2008-03-18 Pelikan Technologies, Inc. Method and apparatus for lancet actuation
CA2448905C (en) 2001-06-12 2010-09-07 Pelikan Technologies, Inc. Blood sampling apparatus and method
US7981056B2 (en) 2002-04-19 2011-07-19 Pelikan Technologies, Inc. Methods and apparatus for lancet actuation
US8337419B2 (en) 2002-04-19 2012-12-25 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
ATE485766T1 (en) 2001-06-12 2010-11-15 Pelikan Technologies Inc ELECTRICAL ACTUATING ELEMENT FOR A LANCET
US7025774B2 (en) 2001-06-12 2006-04-11 Pelikan Technologies, Inc. Tissue penetration device
US9427532B2 (en) 2001-06-12 2016-08-30 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US9226699B2 (en) 2002-04-19 2016-01-05 Sanofi-Aventis Deutschland Gmbh Body fluid sampling module with a continuous compression tissue interface surface
WO2002100254A2 (en) 2001-06-12 2002-12-19 Pelikan Technologies, Inc. Method and apparatus for lancet launching device integrated onto a blood-sampling cartridge
US8702624B2 (en) 2006-09-29 2014-04-22 Sanofi-Aventis Deutschland Gmbh Analyte measurement device with a single shot actuator
US7297122B2 (en) 2002-04-19 2007-11-20 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8579831B2 (en) 2002-04-19 2013-11-12 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7648468B2 (en) 2002-04-19 2010-01-19 Pelikon Technologies, Inc. Method and apparatus for penetrating tissue
US7901362B2 (en) 2002-04-19 2011-03-08 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7226461B2 (en) 2002-04-19 2007-06-05 Pelikan Technologies, Inc. Method and apparatus for a multi-use body fluid sampling device with sterility barrier release
US7717863B2 (en) 2002-04-19 2010-05-18 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7976476B2 (en) 2002-04-19 2011-07-12 Pelikan Technologies, Inc. Device and method for variable speed lancet
US7491178B2 (en) 2002-04-19 2009-02-17 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7547287B2 (en) 2002-04-19 2009-06-16 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7909778B2 (en) 2002-04-19 2011-03-22 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7674232B2 (en) 2002-04-19 2010-03-09 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8784335B2 (en) 2002-04-19 2014-07-22 Sanofi-Aventis Deutschland Gmbh Body fluid sampling device with a capacitive sensor
US9314194B2 (en) 2002-04-19 2016-04-19 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
US8267870B2 (en) 2002-04-19 2012-09-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for body fluid sampling with hybrid actuation
US7291117B2 (en) 2002-04-19 2007-11-06 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US9795334B2 (en) 2002-04-19 2017-10-24 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US7331931B2 (en) 2002-04-19 2008-02-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7892183B2 (en) 2002-04-19 2011-02-22 Pelikan Technologies, Inc. Method and apparatus for body fluid sampling and analyte sensing
US9248267B2 (en) 2002-04-19 2016-02-02 Sanofi-Aventis Deustchland Gmbh Tissue penetration device
US7229458B2 (en) 2002-04-19 2007-06-12 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US7371247B2 (en) 2002-04-19 2008-05-13 Pelikan Technologies, Inc Method and apparatus for penetrating tissue
US7232451B2 (en) 2002-04-19 2007-06-19 Pelikan Technologies, Inc. Method and apparatus for penetrating tissue
US8221334B2 (en) 2002-04-19 2012-07-17 Sanofi-Aventis Deutschland Gmbh Method and apparatus for penetrating tissue
US8574895B2 (en) 2002-12-30 2013-11-05 Sanofi-Aventis Deutschland Gmbh Method and apparatus using optical techniques to measure analyte levels
WO2004060163A1 (en) * 2002-12-30 2004-07-22 Roche Diagnostics Gmbh Capilary tube tip design to assist blood flow
WO2004107964A2 (en) 2003-06-06 2004-12-16 Pelikan Technologies, Inc. Blood harvesting device with electronic control
WO2006001797A1 (en) 2004-06-14 2006-01-05 Pelikan Technologies, Inc. Low pain penetrating
EP1671096A4 (en) 2003-09-29 2009-09-16 Pelikan Technologies Inc Method and apparatus for an improved sample capture device
EP1680014A4 (en) 2003-10-14 2009-01-21 Pelikan Technologies Inc Method and apparatus for a variable user interface
EP1706026B1 (en) 2003-12-31 2017-03-01 Sanofi-Aventis Deutschland GmbH Method and apparatus for improving fluidic flow and sample capture
US7822454B1 (en) 2005-01-03 2010-10-26 Pelikan Technologies, Inc. Fluid sampling device with improved analyte detecting member configuration
US7169116B2 (en) * 2004-04-29 2007-01-30 Lifescan, Inc. Actuation system for a bodily fluid extraction device and associated methods
US8828203B2 (en) 2004-05-20 2014-09-09 Sanofi-Aventis Deutschland Gmbh Printable hydrogels for biosensors
EP1765194A4 (en) 2004-06-03 2010-09-29 Pelikan Technologies Inc Method and apparatus for a fluid sampling device
US8652831B2 (en) 2004-12-30 2014-02-18 Sanofi-Aventis Deutschland Gmbh Method and apparatus for analyte measurement test time
TW200918022A (en) * 2007-10-26 2009-05-01 Delta Electronics Inc Bleeding apparatus
EP2265324B1 (en) 2008-04-11 2015-01-28 Sanofi-Aventis Deutschland GmbH Integrated analyte measurement system
KR100912202B1 (en) * 2008-07-03 2009-08-14 (주)보성메디텍 One body lancet and no pain type blood collecting device
US9375169B2 (en) 2009-01-30 2016-06-28 Sanofi-Aventis Deutschland Gmbh Cam drive for managing disposable penetrating member actions with a single motor and motor and control system
US8965476B2 (en) 2010-04-16 2015-02-24 Sanofi-Aventis Deutschland Gmbh Tissue penetration device
WO2012033835A2 (en) * 2010-09-07 2012-03-15 Innova Medical Design LLC Systems, methods, and devices for reducing the pain of glucose monitoring and insulin adminstration in diabetic patients

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE20001161U1 (en) * 2000-01-19 2000-08-17 Zisser Michael Lancet device for puncturing the skin
US20020082522A1 (en) * 1996-05-17 2002-06-27 Douglas Joel S. Blood and interstitial fluid sampling device
US20030069509A1 (en) * 2001-10-10 2003-04-10 David Matzinger Devices for physiological fluid sampling and methods of using the same

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04244172A (en) * 1991-01-30 1992-09-01 Sony Corp Analgenic method and apparatus with low frequency therapeutic apparatus
JPH0584313A (en) * 1991-07-23 1993-04-06 Sony Corp Electrode for low frequency pain removing device
JP3263854B2 (en) * 1992-02-21 2002-03-11 ソニー株式会社 Electrode for painkiller
US5582184A (en) * 1993-10-13 1996-12-10 Integ Incorporated Interstitial fluid collection and constituent measurement
US5752512A (en) * 1995-05-10 1998-05-19 Massachusetts Institute Of Technology Apparatus and method for non-invasive blood analyte measurement
US6706000B2 (en) * 1997-11-21 2004-03-16 Amira Medical Methods and apparatus for expressing body fluid from an incision
US6231531B1 (en) * 1999-04-09 2001-05-15 Agilent Technologies, Inc. Apparatus and method for minimizing pain perception
JP2002168861A (en) * 2000-11-28 2002-06-14 Terumo Corp Apparatus for measuring component
US6503209B2 (en) * 2001-05-18 2003-01-07 Said I. Hakky Non-invasive focused energy blood withdrawal and analysis system
JP2004008413A (en) * 2002-06-05 2004-01-15 Advance Co Ltd Simple blood collecting utensil, and blood collecting method
US20040254599A1 (en) * 2003-03-25 2004-12-16 Lipoma Michael V. Method and apparatus for pre-lancing stimulation of puncture site
US20040267299A1 (en) * 2003-06-30 2004-12-30 Kuriger Rex J. Lancing devices and methods of using the same

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020082522A1 (en) * 1996-05-17 2002-06-27 Douglas Joel S. Blood and interstitial fluid sampling device
DE20001161U1 (en) * 2000-01-19 2000-08-17 Zisser Michael Lancet device for puncturing the skin
US20030069509A1 (en) * 2001-10-10 2003-04-10 David Matzinger Devices for physiological fluid sampling and methods of using the same

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102921102A (en) * 2006-03-03 2013-02-13 基因特伦尼克斯公司 Method and device for treating microscopic tumors remaining in tissues following surgical resection
WO2009016634A3 (en) * 2007-08-01 2009-03-26 Syneron Medical Ltd Method and device for collagen growth stimulation
US8135475B2 (en) 2007-08-01 2012-03-13 Syneron Medical Ltd. Method and device for collagen growth stimulation
KR101534882B1 (en) * 2007-08-01 2015-07-07 시네론 메디컬 리미티드 Device for collagen growth stimulation
US10610684B2 (en) 2008-01-17 2020-04-07 Genetronics, Inc. Variable current density single needle electroporation system and method
US8321012B2 (en) 2009-12-22 2012-11-27 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
US8364258B2 (en) 2009-12-22 2013-01-29 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
US8725251B2 (en) 2009-12-22 2014-05-13 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject
US8788037B2 (en) 2009-12-22 2014-07-22 The Invention Science Fund I, Llc Device, method, and system for neural modulation as vaccine adjuvant in a vertebrate subject

Also Published As

Publication number Publication date
US20050209625A1 (en) 2005-09-22
CN1925789A (en) 2007-03-07
EP1722683A1 (en) 2006-11-22
CA2557804A1 (en) 2005-10-13
JP2007526057A (en) 2007-09-13

Similar Documents

Publication Publication Date Title
US20050209625A1 (en) Method and apparatus for electrical stimulation to enhance lancing device performance
Bishop Responses to electrical stimulation of single sensory units of skin
US6332871B1 (en) Blood and interstitial fluid sampling device
US7828749B2 (en) Blood and interstitial fluid sampling device
US6503209B2 (en) Non-invasive focused energy blood withdrawal and analysis system
US7666150B2 (en) Blood and interstitial fluid sampling device
Wise et al. Wireless implantable microsystems: high-density electronic interfaces to the nervous system
US7758516B2 (en) Method and apparatus for sampling bodily fluid
US7386349B2 (en) Rapid analgesia for skin puncture
US5899922A (en) Manipulation of nervous systems by electric fields
US6733493B2 (en) Laser skin perforator
EP2373220B1 (en) Electrical stimulation device for locating an electrical stimulation point
US20050177071A1 (en) Invasive appliance
WO1997042888A1 (en) Blood and interstitial fluid sampling device
US20120232441A1 (en) Methods, systems, and devices for reducing or eliminating pain resulting from piercing a patient's skin
JPH11506956A (en) Apparatus and method for detecting a nerve
JP2005523097A (en) Equipment for transmission and reception of electrical signals
CN205041400U (en) Novel it is portable through cranium ultrasound stimulation and EEG signal collection device
KR950703889A (en) Methods and and Apparatus for Measuring Uterine Electrical and Mechanical Activity
KR920703150A (en) Transcranial Electrotherapy
Swett et al. Electrical stimulation of peripheral nerve
CA2923890C (en) Venous electrical stimulation apparatus and methods and uses thereof
Salimi et al. Neuronal activity in normal and deafferented forelimb somatosensory cortex of the awake cat
EP4201480B1 (en) Ultrasonic wave acupuncture device
JPH03292959A (en) Acupuncture probe and acupuncture probing and stimulating apparatus

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SM SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DPEN Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2005715640

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2557804

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007501200

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 200580006732.0

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWW Wipo information: withdrawn in national office

Country of ref document: DE

WWP Wipo information: published in national office

Ref document number: 2005715640

Country of ref document: EP